Cookson Peirce & Co. Inc. Has $842,000 Stock Holdings in Option Care Health, Inc. $OPCH

Cookson Peirce & Co. Inc. grew its holdings in Option Care Health, Inc. (NASDAQ:OPCH) by 8.2% in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 25,910 shares of the company’s stock after acquiring an additional 1,966 shares during the quarter. Cookson Peirce & Co. Inc.’s holdings in Option Care Health were worth $842,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds also recently modified their holdings of the business. Stephens Inc. AR bought a new stake in shares of Option Care Health in the second quarter valued at approximately $317,000. VIRGINIA RETIREMENT SYSTEMS ET Al bought a new stake in shares of Option Care Health in the second quarter valued at approximately $348,000. Mutual of America Capital Management LLC boosted its position in shares of Option Care Health by 0.4% in the second quarter. Mutual of America Capital Management LLC now owns 161,867 shares of the company’s stock valued at $5,257,000 after acquiring an additional 681 shares during the period. Allianz Asset Management GmbH boosted its position in shares of Option Care Health by 378.3% in the second quarter. Allianz Asset Management GmbH now owns 35,871 shares of the company’s stock valued at $1,165,000 after acquiring an additional 28,371 shares during the period. Finally, Bridges Investment Management Inc. boosted its position in shares of Option Care Health by 15.4% in the second quarter. Bridges Investment Management Inc. now owns 56,595 shares of the company’s stock valued at $1,838,000 after acquiring an additional 7,564 shares during the period. 98.05% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

OPCH has been the subject of several research reports. TD Cowen initiated coverage on Option Care Health in a research report on Thursday, October 2nd. They issued a “hold” rating and a $30.00 target price for the company. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Option Care Health in a research report on Wednesday, October 8th. Barrington Research reaffirmed an “outperform” rating and issued a $38.00 target price on shares of Option Care Health in a research report on Tuesday, September 23rd. Cowen initiated coverage on Option Care Health in a research report on Thursday, October 2nd. They issued a “hold” rating for the company. Finally, Morgan Stanley began coverage on Option Care Health in a research report on Friday, October 17th. They issued an “overweight” rating and a $35.00 target price for the company. Nine analysts have rated the stock with a Buy rating and four have issued a Hold rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus price target of $35.10.

Option Care Health Stock Performance

Shares of NASDAQ:OPCH opened at $28.29 on Thursday. Option Care Health, Inc. has a twelve month low of $21.39 and a twelve month high of $35.53. The firm has a market cap of $4.59 billion, a PE ratio of 22.63, a price-to-earnings-growth ratio of 1.71 and a beta of 0.88. The company has a debt-to-equity ratio of 0.81, a quick ratio of 1.00 and a current ratio of 1.52. The business has a fifty day moving average of $28.01 and a 200-day moving average of $30.18.

Option Care Health (NASDAQ:OPCH) last announced its earnings results on Wednesday, July 30th. The company reported $0.41 earnings per share for the quarter, beating analysts’ consensus estimates of $0.40 by $0.01. Option Care Health had a return on equity of 17.53% and a net margin of 3.93%.The company had revenue of $1.42 billion during the quarter, compared to analyst estimates of $1.35 billion. During the same period last year, the company posted $0.30 earnings per share. The firm’s quarterly revenue was up 15.4% compared to the same quarter last year. Option Care Health has set its FY 2025 guidance at 1.650-1.720 EPS. On average, equities research analysts predict that Option Care Health, Inc. will post 1.22 EPS for the current fiscal year.

Insider Buying and Selling

In other news, Director Timothy P. Sullivan purchased 20,000 shares of the business’s stock in a transaction that occurred on Thursday, August 21st. The shares were acquired at an average cost of $27.51 per share, for a total transaction of $550,200.00. Following the transaction, the director directly owned 49,229 shares of the company’s stock, valued at approximately $1,354,289.79. The trade was a 68.43% increase in their position. The acquisition was disclosed in a filing with the SEC, which is available at this link. Also, Director Harry M. Jansen Kraemer, Jr. purchased 36,000 shares of the business’s stock in a transaction that occurred on Wednesday, August 20th. The stock was purchased at an average price of $27.15 per share, for a total transaction of $977,400.00. Following the completion of the transaction, the director directly owned 375,390 shares in the company, valued at $10,191,838.50. This trade represents a 10.61% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders bought a total of 59,411 shares of company stock worth $1,627,576 over the last three months. 0.64% of the stock is currently owned by company insiders.

About Option Care Health

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.